This table shows the implantation adverse reactions of SUPPRELIN® LA subcutaneous implant over a period of time ranging from 9 to 18 months.
SERIOUS ADVERSE REACTIONS
Two patients experienced a serious adverse reaction in the 12-month study1,3:
Serious adverse events were reported in the long-term extension phase, including: depression (n=1), aggression (n=2) and apnea and acute bronchopneumonia (n=1). One patient died during the extension phase from acute bronchopneumonia and Dravet syndrome.3